Showing 2,241 - 2,260 results of 108,461 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (nn decrease)) ))', query time: 1.03s Refine Results
  1. 2241
  2. 2242
  3. 2243
  4. 2244
  5. 2245

    Fluorescence of 5-Arylvinyl-5′-Methyl-2,2′-Bipyridyl Ligands and Their Zinc Complexes by Ali H. Younes (1589731)

    Published 2009
    “…The photophysical properties of 5-arylvinyl-5′-methyl-2,2′-bipyridyls (AVMBs, <b>1</b>−<b>9</b>, <b>11</b>) and their zinc complexes were studied. …”
  6. 2246
  7. 2247
  8. 2248
  9. 2249
  10. 2250

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  11. 2251

    Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

    Published 2017
    “…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”
  12. 2252
  13. 2253
  14. 2254
  15. 2255
  16. 2256
  17. 2257
  18. 2258

    Equilibrium queueing analysis in a ride-hailing service with sharing option by Jianfu Wang (6295775)

    Published 2022
    “…First, we discover a tipping point in the hybrid model. When hassle cost decreases to this point, (i) the optimal customer behavior immediately switches from less than 80% sharing customers to 100%, (ii) the optimal arrival rate increases dramatically, and (iii) the rate at which a decreasing hassle cost improves the maximum social welfare significantly increases. …”
  19. 2259

    Table1_A capillary flow-driven microfluidic device for point-of-care blood plasma separation.DOCX by William Brakewood (14189291)

    Published 2022
    “…This system produced plasma with a maximum separation efficiency of 88.5% and achieved a maximum plasma volume of ∼14 μl from a 50 μl whole blood input. …”
  20. 2260